Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study.

PubWeight™: 2.07‹?› | Rank: Top 2%

🔗 View Article (PMID 17449988)

Published in Clin J Pain on May 01, 2007

Authors

Russell K Portenoy1, John T Farrar, Misha-Miroslav Backonja, Charles S Cleeland, Kaity Yang, Michael Friedman, Salvatore V Colucci, Patricia Richards

Author Affiliations

1: Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA. RPortenoy@chpnet.org

Articles citing this

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain (2009) 9.36

Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf (2009) 3.25

Pain sensitivity and opioid analgesia: a pharmacogenomic twin study. Pain (2012) 2.44

Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. Pain (2010) 2.44

Challenges in using opioids to treat pain in persons with substance use disorders. Addict Sci Clin Pract (2008) 1.81

Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study. J Pain (2008) 1.74

Opioids for chronic noncancer pain: To prescribe or not to prescribe-What is the question? Neurology (2015) 1.41

Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol (2008) 1.32

Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety? J Pain Res (2013) 1.20

Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human. Br J Pharmacol (2011) 1.07

The missing p in psychiatric training: why it is important to teach pain to psychiatrists. Arch Gen Psychiatry (2011) 1.04

Correlates of higher-dose opioid medication use for low back pain in primary care. J Pain (2012) 0.99

Opioids, pain, the brain, and hyperkatifeia: a framework for the rational use of opioids for pain. Pain Med (2010) 0.96

Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities. Osteoarthritis Cartilage (2015) 0.91

[Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks]. Schmerz (2015) 0.88

Informed consent in opioid therapy: a potential obligation and opportunity. J Pain Symptom Manage (2012) 0.85

[Opioids in chronic low back pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration]. Schmerz (2015) 0.84

Current practices in cancer pain management in Asia: a survey of patients and physicians across 10 countries. Cancer Med (2015) 0.81

How effective is long-term opioid therapy for chronic noncancer pain? Clin J Pain (2007) 0.80

Opioid pharmacotherapy for chronic noncancer pain: the american experience. Korean J Pain (2013) 0.80

A Comparison of Daily Average Consumption Of Oxycodone Controlled Release (OxyContin CR) And Oxymorphone Extended Release (Opana ER) In Patients With Low Back Pain. P T (2011) 0.79

Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic pain. J Pain Res (2015) 0.79

Gi-DREADD Expression in Peripheral Nerves Produces Ligand-Dependent Analgesia, as well as Ligand-Independent Functional Changes in Sensory Neurons. J Neurosci (2016) 0.77

Controlled-release oxycodone and naloxone in the treatment of chronic low back pain: a placebo-controlled, randomized study. Pain Res Manag (2013) 0.77

Noninterventional study of transdermal fentanyl (fentavera) matrix patches in chronic pain patients: analgesic and quality of life effects. Pain Res Treat (2015) 0.76

Long-term efficacy and safety of oxycodone-naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study. Drug Des Devel Ther (2016) 0.76

Pain treatment with high-dose, controlled-release oxycodone: an Italian perspective. Ther Clin Risk Manag (2008) 0.75

Higher Prescription Opioid Dose is Associated With Worse Patient-Reported Pain Outcomes and More Health Care Utilization. J Pain (2016) 0.75

Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk. Healthcare (Basel) (2016) 0.75

Articles by these authors

Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain (2005) 11.80

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain (2007) 8.89

Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain (2007) 6.98

The prevention and treatment of missing data in clinical trials. N Engl J Med (2012) 6.92

Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66

Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain (2004) 4.72

Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst (2005) 4.51

Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol (2003) 4.27

Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain (2003) 4.24

Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol (2003) 3.80

Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol (2012) 3.65

Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA (2006) 3.49

Assessment: use of epidural steroid injections to treat radicular lumbosacral pain: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2007) 3.26

Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology (2003) 2.62

Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations. Pain (2013) 2.58

Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain (2009) 2.53

Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain (2009) 2.49

Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain. Pain (2007) 2.47

Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications. Am J Gastroenterol (2002) 2.39

Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trial. Clin J Pain (2005) 2.31

Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain (2006) 2.23

Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society's Studies of Cancer Survivors. Cancer (2011) 2.18

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer (2002) 2.17

Electroacupuncture for fatigue, sleep, and psychological distress in breast cancer patients with aromatase inhibitor-related arthralgia: a randomized trial. Cancer (2014) 2.12

Classification of patients with pain based on neuropathic pain symptoms: comparison of an artificial neural network against an established scoring system. Eur J Pain (2006) 2.09

Audience response system: effect on learning in family medicine residents. Fam Med (2004) 1.99

Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation. J Pain Symptom Manage (2012) 1.97

Development of a neuropathic pain questionnaire. Clin J Pain (2003) 1.96

Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial. Lancet Oncol (2012) 1.90

Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain (2012) 1.88

A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation (2004) 1.87

Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer. Complement Ther Med (2006) 1.85

Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain (2010) 1.84

Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors. Cancer (2009) 1.84

Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials. Pain (2008) 1.82

The efficacy of multilevel surgery of the upper airway in adults with obstructive sleep apnea/hypopnea syndrome. Laryngoscope (2008) 1.81

Quality of care indicators for gout management. Arthritis Rheum (2004) 1.77

The impact of modified Hatha yoga on chronic low back pain: a pilot study. Altern Ther Health Med (2004) 1.75

Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine (2004) 1.70

Patient training in cancer pain management using integrated print and video materials: a multisite randomized controlled trial. Pain (2008) 1.69

How should remission from depression be defined? The depressed patient's perspective. Am J Psychiatry (2006) 1.69

Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance. Am J Cardiol (2009) 1.68

Authors' reply to Tendas et al. J Pain Symptom Manage (2013) 1.66

A point system for resident scholarly activity. Fam Med (2009) 1.64

A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain. Pain (2009) 1.64

A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group. J Palliat Med (2010) 1.64

Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck (2007) 1.63

Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain Behav Immun (2010) 1.58

The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients. J Pain Symptom Manage (2002) 1.58

Association of impaired functional status at hospital discharge and subsequent rehospitalization. J Hosp Med (2014) 1.56

Tightly coupled brain activity and cerebral ATP metabolic rate. Proc Natl Acad Sci U S A (2008) 1.53

Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer (2014) 1.53

Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. J Clin Oncol (2006) 1.52

Asking the community about cutpoints used to describe mild, moderate, and severe pain. J Pain (2006) 1.48

Information systems on human resources for health: a global review. Hum Resour Health (2012) 1.48

Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manage (2003) 1.47

The role of statins in cancer therapy. Oncologist (2006) 1.46

The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials (2014) 1.46

Patient-reported outcomes: instrument development and selection issues. Value Health (2007) 1.46

Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control. Cancer (2002) 1.46

Why isn't bupropion the most frequently prescribed antidepressant? J Clin Psychiatry (2005) 1.45

Side effects of opioids during short-term administration: effect of age, gender, and race. Clin Pharmacol Ther (2003) 1.44

Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Med (2007) 1.43

Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation. Cancer (2008) 1.43

Japanese version of the MD Anderson Symptom Inventory: a validation study. J Pain Symptom Manage (2003) 1.42

Development and psychometric testing of an instrument designed to measure chronic pain in dogs with osteoarthritis. Am J Vet Res (2007) 1.41

Perceived controllability modulates the neural response to pain. J Neurosci (2004) 1.41

Pain intensity rating training: results from an exploratory study of the ACTTION PROTECCT system. Pain (2016) 1.39

Translational approaches to treatment-induced symptoms in cancer patients. Nat Rev Clin Oncol (2012) 1.38

Developing brief scales for use in clinical practice: the reliability and validity of single-item self-report measures of depression symptom severity, psychosocial impairment due to depression, and quality of life. J Clin Psychiatry (2006) 1.37

De qi: Chinese acupuncture patients' experiences and beliefs regarding acupuncture needling sensation--an exploratory survey. Acupunct Med (2007) 1.36

Pain in aging community-dwelling adults in the United States: non-Hispanic whites, non-Hispanic blacks, and Hispanics. J Pain (2006) 1.33

Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients. Cancer (2004) 1.32

Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy. Brain Behav Immun (2012) 1.31

New perspectives on the management of diabetic peripheral neuropathic pain. Diab Vasc Dis Res (2006) 1.30

Individual differences in the effects of perceived controllability on pain perception: critical role of the prefrontal cortex. J Cogn Neurosci (2007) 1.30

Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. Oncologist (2011) 1.30

Discovery of thieno[2,3-c]pyridines as potent COT inhibitors. Bioorg Med Chem Lett (2008) 1.30

Expandable gastroretentive dosage forms. J Control Release (2003) 1.27

Ability of the canine brief pain inventory to detect response to treatment in dogs with osteoarthritis. J Am Vet Med Assoc (2008) 1.26

[Validation of the Spanish version of the Brief Pain Inventory in patients with oncological pain]. Med Clin (Barc) (2003) 1.26

Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage (2006) 1.25

Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them. Pain Med (2011) 1.25

Development of a cancer pain assessment tool in Korea: a validation study of a Korean version of the brief pain inventory. Oncology (2004) 1.25

The utility and validity of the modified brief pain inventory in a multiple-dose postoperative analgesic trial. Clin J Pain (2004) 1.24

ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manage (2010) 1.23

Symptom burden in cancer survivorship. J Cancer Surviv (2007) 1.18

Validation study of the korean version of the brief fatigue inventory. J Pain Symptom Manage (2005) 1.18

Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer (2014) 1.17

Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain. J Pain (2006) 1.16

Revised American Pain Society Patient Outcome Questionnaire (APS-POQ-R) for quality improvement of pain management in hospitalized adults: preliminary psychometric evaluation. J Pain (2010) 1.15

Pain education for underserved minority cancer patients: a randomized controlled trial. J Clin Oncol (2004) 1.15

Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Support Care Cancer (2010) 1.15

Assessment of neuropathic pain in primary care. Am J Med (2009) 1.14

Measuring the symptom burden associated with the treatment of chronic myeloid leukemia. Blood (2013) 1.14